Sanofi Stock: price and insider trades · France

Sanofi, founded in 2004, is a Healthcare & Pharma company based in Paris, France. Its directors and officers file their transactions with AMF. 15 insiders have disclosed 30 filings since 18 October 2025.

Open-market activity splits into 13 purchases totalling €467k and 6 sales totalling €3.6M; 8 insiders sit on the buying side and 5 insiders on the selling side. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Natalie BICKFORD filed the largest sale, €1.4M, on 28 May 2026, which represents 0.0016% of the company's market value. Those buying include 7 senior executives and 1 board member.

In the case of 10 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The latest purchase dates back some time: it was published 46 days ago, on 1 September 2026. The median gap between a trade and its publication by AMF is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade.

With 30 filings in twelve months, the company is more active than the median of 6 filings across the 315 companies we follow on the same exchange. The full history, which starts in 2022, counts 32 purchases against 7 sales.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.